Randomized trial · people
MK-677 reversed diet-driven nitrogen loss in 8 healthy adults
Checked against the paper Randomized trialPublished by PepVault
The takeaway
In healthy adults on a low-calorie diet, a week of MK-677 offset the diet's nitrogen loss and raised IGF-I compared with placebo, but this was a short, 8-person trial.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 8
- Published
- 1998
- Journal
- J Clin Endocrinol Metab
What they tested
Could MK-677 taken by mouth undo the protein breakdown caused by cutting calories?
How the study was done
A double-blind, randomized, placebo-controlled crossover trial in 8 healthy volunteers aged 24-39. Each person had two 14-day periods on a restricted diet (18 kcal/kg.day), taking MK-677 25 mg or a placebo (a dummy pill) once daily in the last 7 days of each, with a 14- to 21-day break between periods.

What they found
In the first, diet-only week, daily nitrogen loss was similar before both treatments (-2.67 g/day before MK-677 vs -2.83 g/day before placebo). Nitrogen balance shows whether the body is gaining or losing protein. In the treatment week, mean daily nitrogen balance was 0.31 g/day on MK-677 vs -1.48 g/day on placebo (P < 0.01). IGF-I, a growth-related hormone, averaged 264 ng/mL on MK-677 vs 188 ng/mL on placebo, and IGF binding protein-3 was 3273 vs 2604 ng/mL; peak GH was 55.9 micrograms/L after the first dose and 22.6 micrograms/L after a week, cortisol and prolactin responses were not significantly higher than on placebo, and the drug was generally well tolerated.
What it doesn’t show
This was a very small group of healthy people, and each dosing period lasted only 7 days. It did not test people who are losing protein because of illness, and it measured nitrogen balance and blood markers rather than muscle or strength.
The paper
Murphy et al. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. J Clin Endocrinol Metab. 1998.
The compound
More studies on MK-677
- MK-677 raised IGF-1 but not most function after hip fractureRandomized trial · people · 2011
- MK-677: fat-free mass rose 1.1 kg vs -0.5 kg on placebo at 1 yearRandomized trial · people · 2008
- MK-677: about 50% more stage IV sleep in young adults on 25 mgClinical trial · people · 1997
- Every study on MK-677
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.